X4 PHARMACEUTICALS, INC Warrant, Down Round Feature, (Increase) Decrease in Equity, Amount
X4 PHARMACEUTICALS, INC (XFOR) reported Warrant, Down Round Feature, (Increase) Decrease in Equity, Amount of $287.00 thousand for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Notes
us-gaap:WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount · last filed 2022-11-03
- X4 PHARMACEUTICALS, INC warrant, down round feature, (increase) decrease in equity, amount for the quarter ending 2022-09-30 was $287.00K.
- X4 PHARMACEUTICALS, INC warrant, down round feature, (increase) decrease in equity, amount for the quarter ending 2022-06-30 was $0.00.
- X4 PHARMACEUTICALS, INC warrant, down round feature, (increase) decrease in equity, amount for the quarter ending 2022-03-31 was $2.26M, a 72.58% decline year-over-year.
- X4 PHARMACEUTICALS, INC warrant, down round feature, (increase) decrease in equity, amount for the quarter ending 2021-09-30 was $0.00.
| Period end | Warrant, Down Round Feature, (Increase) Decrease in Equity, Amount 3 month | Warrant, Down Round Feature, (Increase) Decrease in Equity, Amount 6 month | Warrant, Down Round Feature, (Increase) Decrease in Equity, Amount 9 month |
|---|---|---|---|
| 2022-09-30 | $287.00K 10-Q · filed 2022-11-03 | $287.00K derived: sum of 2 quarters · filed 2022-11-03 | $2.55M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-04 | $2.26M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $2.26M 10-Q · filed 2022-05-12 | ||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | $8.24M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-04 | $8.24M 10-Q · filed 2022-08-04 | |
| 2021-03-31 | $8.24M 10-Q · filed 2022-05-12 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-04 | $0.00 derived: sum of 2 quarters · filed 2021-11-04 | $0.00 10-Q · filed 2021-11-04 |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-03 | $0.00 10-Q · filed 2021-08-03 | |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |